# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-016333
Filing Date
2023-05-01
Accepted
2023-05-01 17:17:40
Documents
8
Period of Report
2023-06-15

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | sybx_proxy_2022_final.htm | DEF 14A | 1003881
2 | GRAPHIC | img13968905_0.jpg | GRAPHIC | 2721
3 | GRAPHIC | img13968905_1.jpg | GRAPHIC | 2788
4 | GRAPHIC | img13968905_2.jpg | GRAPHIC | 2721
5 | GRAPHIC | img13968905_3.jpg | GRAPHIC | 3152
6 | GRAPHIC | img13968905_4.jpg | GRAPHIC | 131747
7 | GRAPHIC | img13968905_5.jpg | GRAPHIC | 536339
8 | GRAPHIC | img13968905_6.jpg | GRAPHIC | 434513
| Complete submission text file | 0000950170-23-016333.txt |  | 2538928

Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

EIN.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37566 | Film No.: 23875095
SIC: 2834 Pharmaceutical Preparations